OrthoPediatrics KIDS, a medical device company focused on the pediatric orthopedic market, has recently undergone analysis by five different analysts, leading to a spectrum of viewpoints from bullish to bearish. The evolving sentiments within the past 30 days have been summarized in a table, showcasing the changing perceptions of the company over time.
The analysts have set 12-month price targets for OrthoPediatrics, revealing an average target of $38.2, with a high estimate of $50.00 and a low estimate of $31.00. This marks an increase of 8.12% from the previous average price target of $35.33, indicating a positive outlook on the company’s future performance.
Taking a closer look at recent analyst actions, key analysts such as Rick Wise from Stifel, Mike Matson from Needham, David Turkaly from JMP Securities, Kaila Krum from Truist Securities, and Richard Newitter from Truist Securities have made various adjustments to their ratings and price targets for OrthoPediatrics. These actions reflect the analysts’ reactions to recent developments related to the company and provide insights into their perceptions of its current state.
Analyzing these analyst evaluations alongside relevant financial metrics, such as market capitalization, revenue growth, net margin, return on equity, return on assets, and debt management, can provide investors with a comprehensive view of OrthoPediatrics’ market position. Understanding analyst ratings, price targets, and financial performance metrics can help investors make informed decisions about the company’s potential future performance.
It is important for investors to stay informed and make data-driven decisions when evaluating small-cap stocks like OrthoPediatrics. By tracking analyst ratings and staying up to date on the company’s financial performance, investors can gain valuable insights into the company’s prospects and make informed investment decisions.
In conclusion, the analysis of OrthoPediatrics by financial experts reveals a range of viewpoints and perspectives on the company’s future performance. By considering analyst ratings, price targets, and financial metrics, investors can gain a better understanding of OrthoPediatrics’ market position and make informed decisions about their investment strategies.
